Laboratory Products
Waters Launches Fit-for-Purpose ACQUITY UPLC H-Class Bio System, the First-of-its-Kind Biocompatible UPLC Platform
Jul 07 2010
New System Advances Macromolecule Analysis through Multiple-Mode Chromatographic Capability, Automated Solvent Blending, and Use of Corrosion Resistant Inert Materials.
Waters Corporation introduced the first-of-its-kind Waters® ACQUITY UPLC® H-Class Bio System, expanding the scientific and business benefits of UPLC® Technology for macromolecule analysis by optimizing characterization of biomolecule structures supporting their progression to viable biotherapeutics. The new ACQUITY UPLC H-Class Bio System provides the ultimate in large molecule characterization enabling organizations to gather information on the true value of their possible therapeutic products.
Powered by the ACQUITY UPLC H-Class platform with a flow-through-needle sample manager and quaternary solvent manager, the new system performs multiple chromatographic techniques that are needed to characterize complex biomolecules. Additionally, it features an inert flow path, and leverages Waters Auto●Blend Plus™ Technology to optimize the analysis of proteins, peptides, nucleic acids, and glycans.
Because of the complexity of any given large molecule, biochemists often must employ one or more chromatographic techniques to accurately separate and characterize any given sample. Powered by proven, reliable and robust UPLC capabilities, the ACQUITY UPLC H-Class Bio System has the flexibility to perform four chromatographic modes on a single system: reversed phase, ion exchange (IEX), size exclusion (SEC), and hydrophilic interaction (HILIC). Scientists can now perform all required assays for robust protein characterization on a single UPLC system.
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Nov 27 2024 Istanbul, Turkey
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE